Therasphere® Noteworthy News

28 April 2018

OPTALYSE PE Results Presented at Society for Cardiovascular Angiogr...

BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and Interventions in San Diego, California. The findings further confirm that bilateral pulmonary embolism treated in as little as 2 hours with significantly less tissue plasminogen activator (tPA) than used in previous studies1- as low as 8mg total - show significant improvement in RV/LV ratio over both the short and long term and with a very low mortality rate of 2% and an equally low recurrent PE rate of 2%.

17 May 2016

Healthcare Player BTG on lookout for acquisitions a profits more th...

BTG, the technology healthcare company that develops products to shrink liver tumours and zap blood clots, has enjoyed a “coming of age”, its boss has said, after revealing that profits more than doubled last year.

12 April 2016

New procedure uses tiny beads to blast away liver cancer

Treating cancer that began in the liver or has spread to the liver can often involve months of chemotherapy and painful radiation treatments. But now there’s a new procedure that takes tiny beads that carry a high dose of radiation and sends them straight to the cancer.

5 April 2016

NICE highlights potential role of TheraSphere® for t...

BTG plc (LSE: BTG), a global specialist healthcare company, has today announced the publication of a new medtech innovation briefing (MIB) by NICE (National Institute for Health and Care Excellence) for TheraSphere yttrium-90 glass microsphere therapy.1

30 March 2016

The ‘Pinhole’ Cancer Treatment You’ve Probably Ne...

Imagine an exquisitely precise cancer therapy procedure done through a small opening in the body

7 January 2016

An Army of Glass: The Remarkable Liver Cancer Treatment You Have Pr...

PATIENT PERSPECTIVE When Eleanor Cook’s cancer spread to her liver, it was a sign that something in her treatment regimen had to change.

7 January 2016

Cutting Edge Treatment Improves Prospects For Liver Cancer Patients

RESEARCH ADVANCES In October, iconic buildings throughout the United Kingdom were bathed in pink light. NFL players wore pink on their shoes during games across the U.S. and, in Canada, hundreds attended high-profile galas.

29 September 2015

Eisai Receives Additional Approval in Japan for Vascular Embolisati...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has received additional approval for the vascular embolization device DC Bead® (specially controlled medical device, “DC Bead”) to be used for the treatment of hypervascular tumors and arteriovenous malformations (AVM) in Japan.

5 September 2015

Millions of tiny beads help liver cancer patients

BILLINGS – Millions of tiny glass beads have given some liver cancer patients in Billings another option in their fight against the disease.

28 April 2015

UK Trial of radioactive glass particles to tackle cancer

Cancer treatment with radioactive glass microspheres is to be trialled for the first time in the UK at Oxford's Churchill Hospital.